79201-41-5

Usage

Uses

Used in Pharmaceutical Industry:
1-hexylhydrazine hydrochloride is used as a key intermediate in the synthesis of various pharmaceuticals, including anticancer and neuroprotective agents, due to its versatile reactivity and functional group tolerance.
Used in Agrochemical Industry:
1-hexylhydrazine hydrochloride is used as a building block in the production of agrochemicals, contributing to the development of effective and targeted pest control solutions.
Used in Fine Chemicals Industry:
1-hexylhydrazine hydrochloride is utilized in the synthesis of other fine chemicals, showcasing its broad applicability in various chemical reactions and processes.
It is important to handle 1-hexylhydrazine hydrochloride with caution, as it can be hazardous if not properly managed.

Upstream product

• 66-25-1 hexanal 
• 79201-37-9 tert-butyl 2-hexylidenehydrazinecarboxylate 
• 111-27-3 hexan-1-ol 
• 287729-02-6 N-hexyl-N-tert-butyloxycarbonylaminophthalimide 
• 259870-73-0 1-hexylhydrazinecarboxylic acid tert-butyl ester 

Downstream Products

• 85421-76-7 2-(6-carboxyhexyl)cyclopentanone hexylhydrazone 

Relevant academic research and scientific papers

N-tert-butoxycarbonylaminophthalimide, a versatile reagent for the conversion of alcohols into alkylated tert-butylcarbazates or hydrazines via the Mitsunobu protocol

An efficient two-step method has been developed for the conversion of alcohols to substituted hydrazines. The use of N-tert- butoxycarbonylaminophthalimide as an acid partner in Mitsunobu reactions with a variety of alcohols permits the synthesis of the corresponding monoalkylated tert-butylcarbazates and hydrazines.

2-(6-Carboxyhexyl)cyclopentanone hexylhydrazone. A potent and time-dependent inhibitor of platelet aggregation

Two new azaprostanoids, a hydrazone(3) and hydrazide (4), have been prepared by the condensation of 2-(6-carboxyhexyl)cyclopentanone with n-hexylhydrazine and caproic acid hydrazide. Preliminary results with the stable hydrazide 4 indicate that it inhibits arachidonic acid (AA) induced human platelet aggregation and that, unlike 13-azaprostanoic acid (1), its site of action is at the cyclooxygenase level. Results with the unstable hydrazone derivative 3 indicate it to be a potent and time-dependent inhibitor of AA-induced human platelet aggregation, with its site of action also at the cyclooxygenase level.